Kieron Wesson – Biography
Last update: April 29, 2026Executive profile
Kieron was Senior Executive, Chemistry Manufacturing Controls at Kezar Life Sciences, and Vice President, Drug Manufacturing Development and Chemistry Manufacturing Controls at AN2 Therapeutics. Kieron Wesson joined Aligos Therapeutics in 2025.
Kieron Wesson is currentlyVice President, Head, Chemistry Manufacturing Controls at Aligos Therapeutics - View - Aligos Therapeutics org chart
Create your alert
to follow the career of Kieron Wesson.
Education
Kieron Wesson has a Bachelor of Arts Natural Sciences from University of Cambridge.
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
More about Kieron Wesson
Selected links
Do you need to know more about Kieron Wesson? More results.
Participate
Social media
- Kieron Wesson on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kieron Wesson
The colleagues of Kieron Wesson
Company Colleagues
- At Aligos Therapeutics, Kieron Wesson has 27 colleagues including Lawrence Blatt (CEO & Chairman), Peter Hirth (Director)…
Industry Colleagues
- In the Biotechnology industry, Kieron Wesson has 35,927 colleagues in 2,426 companies located in 45 countries. 16,995 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Kieron Wesson.
Get in Touch
Here are a few tips for establishing great contacts.
